Search

everythinglearnresearchcommunity

for

Search:↓

The 2003 consensus updated PCOS diagnosis criteria and linked PCOS to higher risks of diabetes and heart problems, recommending lifestyle changes to lower these risks.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

The French Endocrine Society suggests diagnosing PCOS with two of three signs, recommends lifestyle changes and clomiphene for treatment, and calls for more research on certain treatments and tests.

The oral glucose tolerance test is effective in detecting abnormal glucose tolerance in Indian women with PCOS.

Obese women with PCOS have more cardiovascular risk factors, and waist-to-stature ratio is a better health marker than waist-to-hip ratio.

The combined Myo-inositol and D-chiro-inositol treatment improved weight, hormone levels, and skin conditions in women with PCOS.

Mild thyroid issues don't affect the metabolism and hormones of women with PCOS.

Certain gene variations might help protect against insulin resistance and glucose intolerance in people with Polycystic Ovary Syndrome.

Women with androgenetic alopecia (AGA) are more insulin resistant than healthy women, with various insulin sensitivity indices being higher in the AGA group. An oral glucose tolerance test is suggested for women with AGA.

Metformin improved insulin resistance and BMI in overweight Taiwanese women with PCOS, and a 2-hour insulin test may be a good screening tool.

The 2023 guideline advises a detailed approach for PCOS, focusing on early detection, lifestyle and medical treatments, and managing health risks.

Women with PCOS should have an oral glucose tolerance test for effective diabetes screening.

Late dumping syndrome after fundoplication can be diagnosed with an oral glucose tolerance test and managed with diet changes.

Older age, higher BMI, and family history of diabetes increase the risk of gestational diabetes in pregnant women.

The medication combination did not affect glucose tolerance but increased some cholesterol levels due to its estrogen component.

The document concludes that more research is needed to include new treatments in guidelines for Polycystic Ovary Syndrome (PCOS).

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Taking low-dose spironolactone and metformin together works better for PCOS symptoms than either drug alone.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

Indian women with PCOS from Delhi and Srinagar show different symptoms, with Delhi women having higher obesity and blood sugar issues, and Srinagar women showing more hair growth and testosterone levels.

A woman with acromegaly experienced severe hair loss from a drug called Lanreotide Autogel, which improved after stopping the treatment.

Women with PCOS who have high male hormone levels often also have insulin resistance.

Hair loss is linked to insulin resistance in women, regardless of hormone levels.

Higher SFRP-4 levels were found in people without a diabetic family history.

Obese and lean women with PCOS have different symptoms and need different treatments.

Hibiscus syriacus L. flower extracts may help lower blood sugar and improve cholesterol in diabetes.

Skin conditions can signal diabetes and insulin resistance.